HOXA7 and familial pancreatic carcinoma: It was also demonstrated that Antp-TPR peptide had a significant antitumor activity in mice xenografted with human pancreatic cancer (BXPC3) causing loss of CDK4, which is one of Hsp90 client proteins in tumors.